• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » agitation

Items Tagged with 'agitation'

ARTICLES

Expert Q&A

Managing Behavioral and Psychological Disturbances in the Nursing Home

April 1, 2024
Maureen C. Nash, MD
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CGPR_QA2_Maureen-Nash.jpgMaureen C. Nash, MD.

Medical Director, Providence ElderPlace PACE Oregon. Co-editor, Neurocognitive Behavioral Disorders: An Interdisciplinary Approach to Patient-Centered Care (Springer; 2019). All comments are Dr. Nash’s personal views and not those of any organization.

Dr. Nash has no financial relationships with companies related to this material.

Dr. Maureen Nash shares how CMS regulations for using antipsychotics in nursing homes affects quality of care.


Read More
Research Update

Sublingual Dexmedetomidine for Acute Agitation in Bipolar Disorder

January 31, 2024
Sébastien Hardy, PharmD, BCPS.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Sébastien Hardy, PharmD, BCPS. Dr. Hardy has no financial relationships with companies related to this material.

Sublingual dexmedetomidine was found to work effectively and quickly for mild to moderate agitation in patients with bipolar disorder.


Read More
Clinical Update

Inpatient Use of Benzodiazepines for Patients With Substance Use Disorders

January 31, 2024
Audrey Abelleira, PharmD, BCPP
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Audrey Abelleira, PharmD, BCPP. Clinical pharmacist practitioner, VA Connecticut Healthcare System; clinical instructor, Yale School of Medicine, New Haven, CT.

Dr. Abelleira has no financial relationships with companies related to this material.

Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.


Read More
CGPR_shutterstock_1433830391.png
Expert Q&A

Cannabis Use for Managing Agitation in Dementia

January 1, 2024
Aaron Greenstein, MD.
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_Aaron Greenstein_Headshot.jpgAaron Greenstein, MD.

Geriatric psychiatrist in private practice, Denver, CO. Dr. Greenstein is a medical advisor for BrainCheck, Sensi.AI, and Optimize VBC. He is a consultant for GE Healthcare and LEK Consulting.

Relevant financial relationships listed for the author have been mitigated.

Dr. Aaron Greenstein describes when to use dronabinol and dispensary cannabis products for treating agitation in dementia.


Read More
News of Note

Brexpiprazole

October 31, 2023
Stephanie Collier, MD and Talia Puzantian, PharmD, BCPP
From The Carlat Geriatric Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Stephanie Collier, MD, MPH, and Talia Puzantian, PharmD. Dr. Collier and Dr. Puzantian have no financial relationships with companies related to this material. 

Consider other treatments before reaching for brexpiprazole, even though it’s FDA-approved to treat agitation in dementia due to Alzheimer’s disease. 


Read More
Research Update

Antipsychotics in Inpatient Children and Adolescents with Seclusion and Restraint

August 1, 2023
Susie Morris, MD.
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Susie Morris, MD. Dr. Morris has no financial relationships with companies related to this material

How effective are antipsychotic agents in reducing agitation in kids? According to this study, they don’t seem all that helpful, at least not in terms of reducing kids’ time in seclusion or restraints. While several confounding factors complicate the authors’ conclusions, try alternative interventions, like behavioral approaches, until we have more definitive data.
Read More
canstockphoto12099447.jpg
Expert Q&A

Management of Aggressive Behavior in Children and Adolescents on the Inpatient Unit and Emergency Department

August 1, 2023
Vera Feuer, MD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CHPR_QA1_Feuer_Headshot.jpgVera Feuer, MD.

Director, Pediatric Emergency Psychiatry and Behavioral Health Urgent Care, Cohen Children’s Medical Center; Associate Professor, Psychiatry, Pediatrics and Emergency Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY. 

Dr. Feuer has no financial relationships with companies related to this material.

Clinical Update

Confused About Acute Confusional States? A Primer on Delirium

April 1, 2023
Michael Strong, MD and Alexander Thompson, MD, MBA, MPH
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Michael Strong, MD. Assistant professor of clinical psychiatry, Perelman School of Medicine at the University of Pennsylvania. Philadelphia, PA.
Alexander Thompson, MD, MBA, MPH. Clinical professor of psychiatry and emergency medicine; director, C-L Psychiatry, University of Iowa. Iowa City, IA. 
Dr. Strong and Dr. Thompson have no financial relationships with companies related to this material.

Delirium is widespread among patients in ICUs and surgery units. We review the workup and management of this common condition and give you tips to help prevent it in high-risk patients.


Read More
psychosis.jpeg
Expert Q&A

Recognizing and Treating Substance-Induced Psychosis

April 1, 2023
David Beckmann, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA1_Beckmann headshot_color.jpgDavid Beckmann, MD, MPH. 

Assistant professor of psychiatry and human behavior, Sidney Kimmel Medical College, Thomas Jefferson University. Philadelphia, PA.

Dr. Beckmann has no financial relationships with companies related to this material.

Clinical pearls on how to assess and treat substance-induced psychosis when you come across them in your clinic.


Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.